期刊文献+

脂质体紫杉醇联合顺铂对晚期宫颈癌术前化疗的疗效观察 被引量:6

Efficacy of paclitaxel combined with cisplatin chemotherapy for patients with locally advanced cervical cancer
下载PDF
导出
摘要 目的探讨脂质体紫杉醇联合顺铂用于治疗局部晚期宫颈癌患者的临床疗效和不良反应。方法选择2005年5月至2009年5月我院收治的局部晚期宫颈癌患者78例,按就诊顺序将患者分为顺铂联合5-氟尿嘧啶组(PF组,39例)和脂质体紫杉醇联合顺铂组(Taoxl组,39例)。PF组患者采用顺铂联合5-氟尿嘧啶化疗方案,Taxol组患者采用脂质体紫杉醇联合顺铂化疗方案。2组患者化疗后均全麻下行广泛子宫切除术和盆腔淋巴结清扫术,评价并比较2组患者的临床疗效、不良反应和术后3年生存率。结果 PF组患者不良反应主要为消化道反应、口腔黏膜炎和骨髓抑制,Taxol组患者的不良反应主要有骨髓抑制、口腔黏膜炎和肾脏毒性。Taxol组患者的化疗后完全缓解率30.77%,高于PF组的10.26%(χ2=5.032,P=0.025)。Taxol组和PF组患者平均生存时间分别是33.5个月和34.7个月,3年生存率分别为59.6%和70.2%,差异无统计学意义(χ2=1.859,P=0.173)。结论 2种化疗方案患者不良反应差别较大,脂质体紫杉醇联合顺铂化疗方案临床疗效优于顺铂联合5-Fu化疗方案。 Objective To explore the clinical efficacy and side effects of paclitaxel combined with cisplatin chemotherapy for patients with locally advanced cervical cancer. Methods From May 2008 to May 2009,78 patients with locally advanced cervical cancer in our hos-pital were randomly divided into PF group (39 cases) and Taxol group (39 cases). Patients from PF group were treated with cisplatin com-bined 5-Fu while patients in Taxol group were cured with paclitaxel combined with cisplatin. After chemotherapy,all patients were given anes-thesia extensive hysterectomy and pelvic lymph node dissection. The clinical efficacy,side effects and three-year survival of 2 groups were as-sessed and compared. Results The main adverse reactions of PF group were gastrointestinal reactions,oral mucositis and bone marrow sup-pression;the major side effects of Taxol group were bone marrow suppression,oral mucositis and renal toxicity. After chemotherapy,the com-plete remission rate of Taxol group reached 30. 77%,which was higher than that of PF group 10. 26% (χ2 =5. 032,P=0. 025). The average survival time of PF group and Taxol group were 33. 5 months and 34. 7 months,the three-year survival were 59. 6% and 70. 2%,respectively (χ2 =1. 859,P=0. 173),and the difference was not statistically significant. Conclusion The adverse effects of different chemotherapy were observed in 2 groups. The clinical efficacy of Taxol group were better than that of PF group.
出处 《局解手术学杂志》 2014年第2期140-143,共4页 Journal of Regional Anatomy and Operative Surgery
关键词 5-氟尿嘧啶 紫杉醇 顺铂 晚期宫颈癌 化疗 5-fluorouracil paclitaxel cisplatin advanced cervical cancer chemotherapy
  • 相关文献

参考文献16

  • 1HuangL,ZhengM,ZhouQM,etal.Identificationofa7genesignaturethatpredictsrelapseandsurvivalforearlystagepatientswithcervicalcarcinoma[J].MedOncol,2012,29(4):2911-2918.
  • 2BeriwalS,KannanN,SukumvanichP,etal.Completemetabolicresponseafterdefinitiveradiationtherapyforcervicalcancer:patternsandfactorspredictingforrecurrence[J].GynecolOncol,2012,127(2):303-306.
  • 3MorenoAcostaP,GamboaO,SanchezdeGomezM,etal.IGF1RgeneexpressionasapredictivemarkerofresponsetoionizingradiationforpatientswithlocallyadvancedHPV16positivecervicalcancer[J].AnticancerRes,2012,32(10):4319-4325.
  • 42010年NCCN宫颈癌临床实践指南(中国版)[M].2010:M5-7,MS-9.
  • 5王慧霞.老年宫颈癌患者腹腔镜下广泛子宫切除及盆腔淋巴结清扫术临床疗效分析[J].中国老年学杂志,2011,31(24):4785-4786. 被引量:8
  • 6BjelicRadisicV,JensenPT,VlasicKK,etal.Qualityoflifecharacteristicsinpatientswithcervicalcancer[J].EurJCancer,2012,48(16):3009-3018.
  • 7WamaiRG,AyissiCA,OduwoGO,etal.AssessingtheeffectivenessofacommunitybasedsensitizationstrategyincreatingawarenessaboutHPV,cervicalcancerandHPVvaccineamongparentsinNorthWestCameroon[J].JCommunityHealth,2012,37(5):917-926.
  • 8FriedlanderM,KayeSB,SullivanA,etal.Cervicalcarcinoma:adrugresponsivetumorexperiencewithcombinedcisplatin,vinblastine,andbleomycintherapy[J].GynecolOncol,1983,16(2):275-281.
  • 9AngioliR,PlottiF,MonteraR,etal.Neoadjuvantchemotherapyplusradicalsurgeryfollowedbychemotherapyinlocallyadvancedcervicalcancer[J].GynecolOncol,2012,127(2):290-296.
  • 10FurusakaT,AsakawaT,TanakaA,etal.Efficacyofmultidrugsuperselectiveintraarterialchemotherapy(docetaxel,cisplatin,and5fluorouracil)usingtheSeldingertechniquefortonguecancer[J].ActaOtolaryngol,2012,132(10):1108-1114.

二级参考文献5

共引文献7

同被引文献81

  • 1卢建军,张林燕.紫杉醇与顺铂联合化疗治疗宫颈癌的疗效及与组织微血管和微淋巴管密度的关系[J].中国生化药物杂志,2014,34(5):92-94. 被引量:10
  • 2赵淑萍,王泽华.紫杉醇联合顺铂用于局部晚期宫颈癌新辅助化疗近期疗效观察[J].华中医学杂志,2006,30(1):43-44. 被引量:21
  • 3王予祺,常琪,唐劲天.蛇莓化学成分和药理作用的研究进展[J].世界科学技术-中医药现代化,2007,9(2):107-110. 被引量:12
  • 4Philip J,William T.临床妇科肿瘤学[M].郎景和,沈铿,向阳,等,译.北京:人民卫生出版社,2003.346.
  • 5Huang L, Zheng M, Zhou QM, et al. Identification of a 7-gene signature that predicts relapse and survival for ear- ly stage patients with cervical carcinoma[J]. Med Oncol, 2012,29(4) :2 911.
  • 6Beriwal S, Kannan N, Sukumvanich P, et al. Complete metabolic response after definitive radiation therapy for cervical cancer: patterns and factors predicting for recur- rence[J]. Gynecol Oncol, 2012,127 (2):303.
  • 7Moreno-Acosta P, Gamboa O, Sanchez de Gomez M, et al. IGF1R gene expression as a predictive marker of re- sponse to ionizing radiation for patients with locally ad- vanced HPV16-positive cervical cancer[J]. Anticancer Re- s,2012,32(10) :4 319.
  • 8Bjelic-Radisic V, Jensen PT, Vlasic KK, et al. Quality of life characteristics inpatients with cervical cancer [J]. Eur J Cancer, 2012,48(16) : 3 009.
  • 9Higgins JPT, Altman DG. Chapter 8:Assessing risk of bi- as in included studies[EB/OL]. (2011-03)[2014-09-10]. http://www.cochrane-handbook.org.
  • 10Jadad AR, Moore A, Carroll D, et aL Assessing the quali- ty of reports of randomized clinical trials: is blinding nec- essary?[J]. Control Clin Trials, 1996,17( 1 ) : 1.

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部